Caroline Bertozzi

Title: Caroline Bertozzi: Innovator in Selectin Binding Inhibition

Introduction

Caroline Bertozzi is a prominent inventor based in Albany, CA (US). She has made significant contributions to the field of biochemistry, particularly in the area of cell binding inhibition. With a total of 2 patents, her work has implications for treating inflammatory and immunological conditions.

Latest Patents

One of her latest patents focuses on the inhibition of selectin binding. This invention provides compositions that inhibit the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently crosslinked lipid composition is prepared, which includes saccharides and acidic groups on separate lipids. The composition is interposed between the cells to inhibit binding. Notably, inhibition can be achieved at an effective oligosaccharide concentration as low as 10^6 fold below that of the free saccharide. Since selectins are involved in recruiting cells to sites of injury, these compositions can be utilized to palliate certain inflammatory and immunological conditions.

Career Highlights

Caroline Bertozzi is affiliated with the University of California, where she continues her research and innovation. Her work has garnered attention for its potential applications in medical science and therapeutic development.

Collaborations

Some of her notable coworkers include Jon O Nagy and Wayne R Spevak. Their collaborative efforts contribute to the advancement of research in the field.

Conclusion

Caroline Bertozzi's innovative work in selectin binding inhibition showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact the treatment of various inflammatory and immunological conditions.